McArdle Trainee Seminar Series (Student/Postdoc)

This event has passed.

6571 WIMR II

BRD8 is a therapeutic bfor overcoming resistance to dual ER/HER2 blockade therapy in HR+/HER2+ breast cancer Ang Gao, PhD Xu Lab